ArticleJournal of clinical medicine2025

Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis.

Soichi Yagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.